Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Dunning

Showing results (121-130 of 357) with videos related to

Pageof 36
Sort By:
Plos Medicine|February 16, 2006
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS studyStuart H Ralston, André G Uitterlinden, Maria Luisa Brandi, et al.
Journal of the National Cancer Institute|August 14, 2020
Common Susceptibility Loci for Male Breast CancerSarah Maguire, Eleni Perraki, Katarzyna Tomczyk, et al.
Cancer Research|April 6, 2007
A common 8q24 variant in prostate and breast cancer from a large nested case-control studyFredrick R Schumacher, Heather Spencer Feigelson, David G Cox, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2014
A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicityGillian C Barnett, Deborah Thompson, Laura Fachal, et al.
Journal of the National Cancer Institute|March 13, 2008
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysisBernd Frank, Miriam Wiestler, Silke Kropp, et al.
Human Molecular Genetics|February 19, 2009
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformationMiriam S Udler, Kerstin B Meyer, Karen A Pooley, et al.
Journal of the National Cancer Institute|May 17, 2019
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer RadiotherapySarah L Kerns, Laura Fachal, Leila Dorling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate CancerManzur Farazi, Xin Yang, Carson J Gehl, et al.
Human Molecular Genetics|May 21, 2010
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among CaucasiansFredrick R Schumacher, Iona Cheng, Matthew L Freedman, et al.
Cancer Research|February 28, 2007
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal womenChristopher A Haiman, Laure Dossus, V Wendy Setiawan, et al.
Pageof 36

Showing results (121-130 of 357) with videos related to

Sort By:
Pageof 36
Plos Medicine|February 16, 2006
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS studyStuart H Ralston, André G Uitterlinden, Maria Luisa Brandi, et al.
Journal of the National Cancer Institute|August 14, 2020
Common Susceptibility Loci for Male Breast CancerSarah Maguire, Eleni Perraki, Katarzyna Tomczyk, et al.
Cancer Research|April 6, 2007
A common 8q24 variant in prostate and breast cancer from a large nested case-control studyFredrick R Schumacher, Heather Spencer Feigelson, David G Cox, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2014
A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicityGillian C Barnett, Deborah Thompson, Laura Fachal, et al.
Journal of the National Cancer Institute|March 13, 2008
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysisBernd Frank, Miriam Wiestler, Silke Kropp, et al.
Human Molecular Genetics|February 19, 2009
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformationMiriam S Udler, Kerstin B Meyer, Karen A Pooley, et al.
Journal of the National Cancer Institute|May 17, 2019
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer RadiotherapySarah L Kerns, Laura Fachal, Leila Dorling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate CancerManzur Farazi, Xin Yang, Carson J Gehl, et al.
Human Molecular Genetics|May 21, 2010
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among CaucasiansFredrick R Schumacher, Iona Cheng, Matthew L Freedman, et al.
Cancer Research|February 28, 2007
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal womenChristopher A Haiman, Laure Dossus, V Wendy Setiawan, et al.
Pageof 36